awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38056852-D85D7558-26C6-4540-AB7A-514D5783D907
Q38056852-D85D7558-26C6-4540-AB7A-514D5783D907
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38056852-D85D7558-26C6-4540-AB7A-514D5783D907
Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.
P2860
Q38056852-D85D7558-26C6-4540-AB7A-514D5783D907
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38056852-D85D7558-26C6-4540-AB7A-514D5783D907
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
715386d962210317e0dd0205541c8c932be70e82
P2860
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease.